Does the low mood some people notice on Mounjaro go away?

Low mood and emotional changes are listed among the possible side effects of GLP-1 and dual-agonist medicines; they are not guaranteed and do not affect everyone.
For some people, feelings of flatness or reduced emotional response are linked to appetite suppression, which can affect the reward signals associated with food — an effect sometimes called suppression on Mounjaro.
The MHRA asks prescribers and patients to report mood changes, thoughts of self-harm or suicide via Yellow Card so the safety signal can be monitored across the full population using these medicines.
If low mood is severe, sudden or involves thoughts of self-harm, seek medical help the same day, do not wait for the next routine review.

Low mood or depression-like feelings reported during Mounjaro treatment can, for many people, ease as the body adjusts — but they don't always resolve on their own, and the picture is more nuanced than a simple yes. Mounjaro (tirzepatide) affects appetite, gut hormones and metabolic signalling, and any of those changes can influence how you feel mentally in the early weeks. Because these are prescription-only medicines, a prescriber needs to know if low mood persists: it changes what happens next. The rest of this page walks through what is actually known, what typically happens across the treatment timeline, and when the right step is to get clinical help rather than wait it out.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How mood changes on Mounjaro typically unfold, and what to do at each stage

Step 1: Recognise what you're experiencing and when it started

The first, most practically useful step is to notice exactly when the low mood appeared. Did it begin in the first two weeks after starting or after a dose increase? Or has it been building gradually over months? Timing matters because the likely explanation (and the right response) differs between those two patterns.

Early-onset low mood, arriving in the first week or two of a new dose, is sometimes tied to the GI side-effect cluster: persistent nausea, poor sleep from digestive discomfort and a sharp drop in the pleasure most people unconsciously get from eating. Those are real physiological stressors, and feeling flat or irritable because of them is not the same thing as a depressive episode. Many people find this phase settles as nausea eases, usually within two to four weeks. Our page on whether Mounjaro can cause depression goes deeper into the biological mechanisms behind early mood changes.

Mood that appears later in treatment, or that feels qualitatively different from nausea-related flatness, needs closer attention. It may still resolve; it may need to be actively managed. Keeping a brief daily note (mood, sleep, appetite, energy) for two weeks gives a prescriber something concrete to work with rather than a general impression.

Step 2: Understand the suppression effect and whether it's relevant to you

One pattern our clinical team hear described regularly is a feeling of emotional blunting that mirrors the appetite suppression itself. When Mounjaro reduces food cravings and the reward response to eating, some people notice that other sources of pleasure feel muted at the same time. This is not the same as clinical depression, but it can feel alarming, particularly if you weren't expecting it.

This effect (sometimes called food-noise suppression or, in broader terms, what suppression means on Mounjaro) does appear to ease for many people once the body adjusts to the new hormone signalling, and our dedicated page on Mounjaro suppression explains in more detail how that adjustment process tends to unfold. The adjustment period is harder to predict at higher doses. At 10mg or 12.5mg, which carry stronger appetite and reward effects than the 2.5mg starting dose, some people need more time before the emotional tone normalises.

For others, the suppression effect is the first time they have experienced life without constant food preoccupation, and they describe it as relief rather than loss. Individual variation here is wide. There is no single timeline that fits everyone, which is why a prescriber who knows your history is better placed than general guidance to tell you whether waiting is reasonable in your specific case.

Step 3: Know when to act rather than wait

Waiting for adjustment is reasonable for mild, clearly nausea-linked flatness in the first fortnight. It is not the right approach if low mood is persistent, worsening, or accompanied by any thoughts of self-harm. The relationship between Mounjaro and depressive symptoms is still being studied, and the MHRA's Yellow Card system exists precisely to capture individual reports that build the evidence base over time. You can report a suspected side effect directly at yellowcard.mhra.gov.uk.

In practice, a prescriber has several options: reviewing whether a dose reduction would help, deciding whether to pause treatment, or considering whether mood support alongside weight management is the better path. None of these decisions should be made by the patient alone by adjusting their own dose. The NHS tirzepatide medicines page lists mood changes and thoughts of self-harm as effects requiring prompt medical attention, not a watch-and-wait approach, and our own tirzepatide information page covers what patients prescribed this medicine in the UK should know about monitoring their symptoms.

If you are managing treatment through nume, the priority aftercare line is available seven days a week, contact the team through the support page rather than waiting for a scheduled review if symptoms are troubling you.

Step 4: The broader picture, does mood sometimes improve on Mounjaro?

This is worth raising honestly, because the evidence genuinely points in more than one direction. Some people starting GLP-1 treatment report improved mood, reduced anxiety and better energy within the first few months, an effect plausibly connected to early weight loss, improved sleep from reduced joint or reflux symptoms, and the psychological lift of feeling more in control of appetite. Our page on Mounjaro and improved mood covers the emerging evidence on that side of the picture.

The honest answer to whether depression goes away on Mounjaro is therefore: it depends heavily on what's driving it. Nausea-linked flatness in the early weeks often does ease. Persistent or worsening low mood needs clinical review rather than patient-led patience. And for a meaningful number of people, mood actually improves compared with where they started.

Treatment decisions, including whether to continue, adjust or pause, sit with your prescriber. If you haven't started yet and want to understand the full clinical picture before committing, starting a free consultation gives you access to a prescriber who can assess your individual history, including any relevant mental health background, before anything is prescribed.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions